NJOY Fights FDA Over Age Verification and E Cigarette Sales

Author

Reads 1.8K

Woman Hidden Behind E-Cigarette Smoke
Credit: pexels.com, Woman Hidden Behind E-Cigarette Smoke

NJOY, a leading e-cigarette brand, has been at the center of a heated controversy with the FDA. The company has been fighting against the FDA's efforts to regulate e-cigarette sales, particularly when it comes to age verification.

NJOY has been accused of selling e-cigarettes to minors, which led the FDA to take action. According to the FDA, NJOY was selling e-cigarettes online without proper age verification, allowing minors to purchase them.

The FDA's efforts to regulate e-cigarette sales are aimed at reducing the number of youth e-cigarette users. The agency has set a deadline for e-cigarette manufacturers to submit plans for age verification and other safety measures.

NJOY's resistance to the FDA's regulations has sparked concerns about the safety and health risks associated with e-cigarette use, particularly among youth.

NJOY Products

NJOY offers a range of products, including open system vape liquids and closed system vape devices.

Their product portfolio includes the ACE* e-vapor device, available in various flavors with different nicotine levels. The ACE* Pod comes in classic tobacco, rich tobacco, and menthol flavors, with nicotine levels of 2.4% and 5.0% by weight.

Credit: youtube.com, NJOY Daily Review 👎

The NJOY DAILY disposable electronic cigarette is also part of their product line, available in rich tobacco, menthol, extra rich tobacco, and extra menthol flavors, with nicotine levels of 4.5% and 6.0% by weight.

The main ingredients in NJOY's vape liquids are propylene glycol and vegetable glycerin, with additional ingredients including nicotine and flavorings. Lactic acid is also present in the liquid of all flavors of the NJOY DAILY and ACE* products.

NJOY's liquids are blended in the U.S. using domestic and imported ingredients. They also have a resource available to comply with product disclosure requirements set forth in NY Public Health Law, Article 17.

Harm Reduction and Lawsuit

NJOY is advocating for a harm reduction future where the industry operates within science-based regulation and adult smokers can move to smoke-free products authorized by the FDA.

The company points to overwhelming public support for harm reduction as the best path forward for tobacco products.

Credit: youtube.com, Vaping Harm Reduction

Generational lows in underage use of all traditional tobacco products have been achieved, with a national minimum age of 21 helping drive down underage use in all categories.

A scientific consensus exists that while nicotine is addictive, it's smoke from combustion that causes most tobacco-related harm.

A growing consensus also exists that prohibition of adult tobacco products is not the right path forward.

NJOY has filed a lawsuit against the FDA and other defendants, alleging that the agency has failed to act on NJOY's supervisory appeal concerning its flavored disposable vape products.

The delay has kept lawful products out of the market while illicit flavored disposables have flourished across the United States.

Here are some key facts about the lawsuit:

  • NJOY filed the lawsuit on August 21, 2025, in the Western District of Louisiana.
  • The plaintiffs allege that the FDA has failed to act on NJOY’s supervisory appeal for nearly three years.
  • The FDA granted marketing orders for some of NJOY’s products but denied the flavored applications.

Harm Reduction

Harm reduction is a key concept in the tobacco industry, and it's great to see it gaining traction. Overwhelming public support exists for harm reduction as the best path forward for tobacco products.

Credit: youtube.com, Health and Harm Reduction: Rethinking Conventional Drug Use and Policy | Jeffrey Hom | TEDxUSciences

In fact, there are some impressive statistics to back this up. Generational lows in underage use of all traditional tobacco products have been observed, and a national minimum age of 21 has helped drive down underage use in all categories.

One of the main reasons for this is the scientific consensus that while nicotine is addictive, it's smoke from combustion that causes most tobacco-related harm. This understanding has led to a growing consensus that prohibition of adult tobacco products is not the right path forward.

Here are some key points to consider:

  • Over 90% of adult smokers start smoking before the age of 21.
  • Underage use of all traditional tobacco products has reached generational lows.
  • A national minimum age of 21 has helped drive down underage use in all categories.
  • The scientific consensus is clear: smoke from combustion causes most tobacco-related harm.
  • Prohibition of adult tobacco products is not the right path forward.

By focusing on harm reduction, we can create a safer and more sustainable future for adult smokers who can't or won't quit. This means advocating for science-based regulation and supporting the industry's efforts to move towards smoke-free products authorized by the FDA.

Lawsuit Filed

A lawsuit was filed on August 21, 2025, in the Western District of Louisiana by NJOY, an Altria subsidiary, and Louisiana retailers.

Credit: youtube.com, Principles of Harm Reduction | Cato Daily Podcast

The lawsuit was a significant move, marking a turning point in the ongoing battle over flavored vaping products. NJOY had previously faced challenges from regulatory bodies, including the FDA.

In June 2022, the FDA denied flavored NJOY DAILY PMTAs, but surprisingly approved tobacco and menthol variants. This decision was a major setback for the company, which had been banking on the success of its flavored products.

Here's a brief timeline of the key events surrounding the lawsuit:

  • August 21, 2025: NJOY and Louisiana retailers file a lawsuit in the Western District of Louisiana.
  • June 2022: FDA denies flavored NJOY DAILY PMTAs but approves tobacco and menthol variants.

Main Allegations

NJOY, LLC, a subsidiary of Altria, has filed a lawsuit against the FDA and other government agencies, alleging several key issues with the FDA's handling of their flavored disposable vape product applications.

The FDA has been criticized for its inconsistent standards, as tobacco and menthol products were authorized while compositionally identical flavored products were denied.

NJOY's applications for flavored products were denied after 802 days, which is 4.5 times the statutory period of 180 days.

A sleek vape device resting on a wooden surface outdoors in natural light.
Credit: pexels.com, A sleek vape device resting on a wooden surface outdoors in natural light.

The FDA's delay in reviewing NJOY's supervisory appeal has left the matter unresolved for nearly three years, creating a "de facto flavor ban" in the process.

NJOY's flavored applications were denied despite the company's stringent marketing and age-verification measures, which were not meaningfully considered by the FDA.

The FDA's failure to act on NJOY's supervisory appeal has resulted in a severe imbalance in the market, with illicit flavored disposables dominating U.S. retail.

Here are the main allegations against the FDA:

  • Inconsistent standards: Tobacco and menthol products were authorized, while compositionally identical flavored products were denied.
  • Disregard of evidence: FDA failed to give due weight to NJOY's longitudinal data and youth-specific studies.
  • Rejection of safeguards: NJOY's stringent marketing and age-verification measures were not meaningfully considered.
  • Procedural delay: The supervisory appeal has been pending since October 2022, effectively creating a "de facto flavor ban."
  • Market imbalance: Lawful products remain sidelined, while illicit flavored disposables dominate U.S. retail.

Social Media and FDA Interaction

NJOY's social media presence has been a key factor in its marketing efforts. The company has a strong online presence, with millions of followers across various platforms.

NJOY has faced scrutiny from the FDA, particularly regarding its e-liquid flavors. The FDA has sent warning letters to NJOY, citing concerns over the company's flavored products.

NJOY has taken steps to comply with FDA regulations, including removing certain flavors from its product line. This move was likely a strategic decision to avoid further regulatory action.

You might like: Fda Firings Doge

Social Media

Credit: youtube.com, FDA Social Media Changes that May Affect Healthcare

Social media has become a powerful channel for companies to stay connected to their consumers. They're committed to keeping their adult nicotine consumers 21+ at the center of everything they do.

Social media continues to shift how people communicate across the world. This shift has implications for how companies responsibly engage with their adult nicotine consumers 21+.

They're guided by their commitment to marketing responsibly. This includes taking steps designed to limit reach to underage audiences.

Take a look at this: Consumers Credit Union

Allegations Against FDA

NJOY has some serious allegations against the FDA. They claim the agency's handling of their applications and appeal is flawed in several key respects.

One major issue is the inconsistent standards being applied. NJOY argues that tobacco and menthol products were authorized, while compositionally identical flavored products were denied.

The FDA's disregard for evidence is another major concern. NJOY says the agency failed to give due weight to their longitudinal data and youth-specific studies.

Close-up Photo of Packaging of a Product
Credit: pexels.com, Close-up Photo of Packaging of a Product

The FDA's rejection of NJOY's safeguards is also a point of contention. NJOY implemented stringent marketing and age-verification measures, but the FDA didn't meaningfully consider them.

The procedural delay in NJOY's supervisory appeal is staggering. It's been pending since October 2022, effectively creating a "de facto flavor ban."

Here's a breakdown of the timeline:

This delay is a huge imbalance in timing, and NJOY is right to point it out. The FDA is expected to act on PMTAs within 180 days, but NJOY's applications were denied after 802 days.

Related reading: Reg B 30 Days

FDA Interaction Timeline

The FDA Interaction Timeline is a crucial aspect of the story. NJOY submits eight PMTAs, including four flavored variants, on March 30, 2020.

The FDA issues a deficiency letter on December 17, 2020, asking for stronger evidence on the flavored variants. This sets the stage for a prolonged interaction between NJOY and the FDA.

NJOY responds on March 4, 2021, providing six-month longitudinal data. The FDA then issues Marketing Denial Orders (MDOs) for flavored products and grants a Marketing Grant Order (MGO) for the tobacco variant on June 10, 2022.

Consider reading: Aliexpress Issues

Credit: youtube.com, Jeffrey Francer of PhRMA presentation at FDA Social Media Hearing

NJOY files a supervisory appeal on October 17, 2022, but it remains undecided. The then-CTP Director, Brian King, accepts the appeal and delegates it to Shawn Fultz on November 7, 2022.

A series of follow-up letters from NJOY to the FDA go unanswered: January 17, 2024, April 22, 2025, and July 30, 2025. Meanwhile, Bret Koplow is appointed Acting Director of CTP in May 2025.

The lawsuit is formally filed in the Western District of Louisiana on August 21, 2025, marking a significant escalation of the situation.

On a similar theme: 2022 Russian Debt Default

Age Verification and Key Points

NJOY limits access to their website, njoy.com, to adult nicotine consumers 21+.

To verify the age of users, NJOY uses electronic age-verification checks that compare personal information against public-records databases and third-party data sources.

If the records confirm the individual's age, they gain access to the website, but if not, access to the product-branded marketing sections of the website is denied.

NJOY's website is also compatible with age-filtering software, which can be used to block access to websites considered unsuitable for children.

NJOY carefully considers responsible marketing practices in their third-party e-commerce partnerships and is exploring ways to codify their responsibility expectations and monitor adherence to their contractual practices.

Age Verification on Brand Communications

Credit: youtube.com, Enformed Insights Clips: Industry Trends For Age Verification

We limit access to our product-branded website to adult nicotine consumers 21+ through an electronic age verification process.

This process checks the personal information provided by an individual against public-records databases and third-party data sources to verify their age.

If the records confirm the individual's age, they gain access to the website.

If not, access to the product-branded marketing sections of the website is denied.

We also use age-filtering software to block access to websites considered unsuitable for children.

This software is compatible with our website, ensuring that underage persons cannot access it.

We carefully consider responsible marketing practices as we venture into third-party e-commerce partnerships for our products.

To monitor adherence to our contractual responsible marketing practices, we're exploring ways to codify our responsibility expectations.

Here's a summary of our age verification process:

  • Electronic age verification checks personal information against public-records databases and third-party data sources.
  • Access to the website is denied if the records do not confirm the individual's age.
  • Age-filtering software blocks access to websites considered unsuitable for children.

Key Points

Age verification is a crucial aspect of online safety, and it's not just about blocking access to certain websites. In the US, the Children's Online Privacy Protection Act (COPPA) requires websites to obtain parental consent before collecting data from kids under 13.

Orange and white vape pen displayed outdoors against trees and leaves
Credit: pexels.com, Orange and white vape pen displayed outdoors against trees and leaves

The General Data Protection Regulation (GDPR) in the EU takes it a step further, requiring age verification for all online services. This includes social media platforms, online games, and even streaming services.

Age verification methods can be invasive, but they're necessary to prevent children from accessing adult content. For example, some websites use facial recognition technology to verify users' ages.

In the UK, the Digital Economy Act 2017 requires age verification for online pornographic content. This is enforced by the British Board of Film Classification (BBFC).

Age verification can be a complex issue, but it's essential for protecting children's online safety.

A unique perspective: Ingram Content Group

Juul Labs Leads in E-Cigarette Battle

Juul Labs is the leading e-cigarette brand in the US market, with a 32.6% market share in 2020.

Its popularity can be attributed to its wide range of flavors and sleek design.

The company's success is also a result of its early mover advantage, having launched in 2017.

Credit: youtube.com, NJOY CEO on the Rise of E-Cigarettes | Mad Money | CNBC

This allowed it to establish a strong presence in the market before competitors could catch up.

Juul Labs' e-cigarettes are known for their high nicotine levels, which can be as high as 59mg per milliliter.

This is significantly higher than the 20mg per milliliter limit set by the FDA.

The company's focus on convenience and portability has also contributed to its success.

Juul's e-cigarettes are small and easy to use, making them a popular choice among consumers.

In 2020, Juul Labs faced a major setback when the FDA announced a ban on the sale of its flavored e-cigarettes.

This move was a significant blow to the company's business, but it has since adapted to the new regulations.

Frequently Asked Questions

Is NJOY healthier than cigarettes?

While NJOY may be a safer alternative to traditional cigarettes, it's still not a completely safe option. Learn more about the potential risks and benefits of vaping with NJOY

How much does a NJOY cost?

The NJOY Ace Device costs $32.49, plus a delivery fee starting at $3.95. Sign up for Fam membership for free deliveries and get your NJOY Ace Device delivered to you!

Teresa Halvorson

Senior Writer

Teresa Halvorson is a skilled writer with a passion for financial journalism. Her expertise lies in breaking down complex topics into engaging, easy-to-understand content. With a keen eye for detail, Teresa has successfully covered a range of article categories, including currency exchange rates and foreign exchange rates.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.